Aryl imidazoles and their use as anti-cancer agents
Therapeutically effective 2,4,5-trisubstituted imidazole compounds are provided. Also provided are methods of preparing the compounds and pharmaceutical compositions comprising the compounds alone or in combination with other agents. The present invention further provides for the use of the compounds as anti-cancer agents; wherein: R1 is aryl, substituted aryl, heterocycle, substituted heterocycle, heteroaryl, substituted heteroaryl or amino; R2 and R3 are independently aryl, substituted aryl, heterocycle, heteroaryl, substituted heterocycle, or substituted heteroaryl or R2 and R3 when taken together along with the carbon atoms they are attached to, form aryl or substituted aryl, and R4 is hydrogen, halogen, hydroxyl, thiol, lower alkyl, substituted lower alkyl, lower alkenyl, substituted lower alkenyl, lower alkynyl, substituted lower alkynyl, alkylalkenyl, alkyl alkynyl, alkoxy, alkylthio, aryl, aryloxy, amino, amido, carboxyl, aryl, substituted aryl, heterocycle, heteroaryl, substituted heterocycle, heteroalkyl, cycloalkyl, substituted cycloalkyl, alkylcycloalkyl, alkylcycloheteroalkyl, nitro, cyano or —S(O) 0-2 R wherein R is alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, heteroaryl, substituted heterocycle, or substituted heteroaryl.
1. A compound of formula (VI):
or a salt thereof, wherein:
R4, R5, R7 and R8 are independently hydrogen, halogen, hydroxyl, thiol, lower alkyl, substituted lower alkyl, lower alkenyl, substituted lower alkenyl, lower alkynyl, substituted lower alkynyl, alkylalkenyl, alkylalkynyl, alkoxy, alkylthio, acyl, aryloxy, amino, amido, carboxyl, aryl, substituted aryl, heterocycle, heteroaryl, substituted heterocycle, substituted heteroaryl, heteroalkyl, cycloalkyl, substituted cycloalkyl, alkylcycloalkyl, alkylcycloheteroalkyl, nitro, cyano, —CONHHN 2 or —S(O) 0-2 R wherein R is alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, heteroaryl, substituted heterocycle, or substituted heteroaryl;
R6 is hydrogen, halogen, CN, NO 2 , HN 2 , or —OR, wherein R is C1-C10 alkyl or arylalky;
R9 is hydrogen, C1-C10 alkyl, aryl, or halogen;
x is CR11;
y is CR12 or N;
z is CR13 or N;
r is CR14 or N;
x′ is CR15;
y′ is CR16 or N;
z′ is CR17 or N;
r′ is CR18 or N;
R10 is H, lower alkyl, substituted lower alkyl, lower alkenyl, substituted lower alkenyl, lower alkynyl, substituted lower alkynyl, methoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, acyl or —SO 2 PhCH 3 ;
R11, R12, R14, R15, R16, and R18 are independently hydrogen, halogen, hydroxyl, thiol, lower alkyl, substituted lower alkyl, lower alkenyl, substituted lower alkenyl, lower alkynyl, substituted lower alkynyl, alkylalkenyl, alkylalkynyl, alkoxy, alkylthio, acyl, aryloxy, amino, amido, carboxyl, aryl, substituted aryl, heterocycle, heteroaryl, substituted heterocycle, substituted heteroaryl, heteroalkyl, cycloalkyl, substituted cycloalkyl, alkylcycloalkyl, alkylcycloheteroalkyl, nitro, cyano, —N═CRR′, wherein R and R′ are independently selected from H, alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, substituted heterocycle, heteroaryl, substituted heteroaryl; or —NHC(S)NH-phenyl (substituted or unsubstituted); and,
R13 and R17 are independently hydrogen, halogen, hydroxyl, thiol, lower alkyl, substituted lower alkyl, lower alkenyl, substituted lower alkenyl, lower alkynyl, substituted lower alkynyl, alkylalkenyl, alkylalkynyl, alkoxy, alkylthio, acyl, aryloxy, amino, amido, carboxyl, aryl, substituted aryl, heterocycle, heteroaryl, substituted heterocycle, substituted heteroaryl, heteroalkyl, cycloalkyl, substituted cycloalkyl, alkylcycloalkyl, alkylcycloheteroalkyl, nitro, cyano, —N═CRR′, wherein R and R′ are independently selected from H, alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, substituted heterocycle, heteroaryl, substituted heteroaryl; or —NHC(S)NH-phenyl (substituted or unsubstituted).
2. The compound accordingly to claim 1 , wherein:
R4, R5, R7 and R8 are independently hydrogen, halogen, hydroxyl, thiol, lower alkyl, substituted lower alkyl, alkoxy, alkylthio, acyl, aryloxy, amino, amido, carboxyl, aryl, substituted aryl, nitro, cyano, —CONHHN 2 or —S(O) 0-2 R wherein R is alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, heteroaryl, substituted heterocycle, or substituted heteroaryl.
3. The compound according to claim 1 , wherein:
x is CR11;
y is CR12;
z is CR13;
r is CR14;
x′ is CR15;
y′ is CR16;
z′ is CR17; and
r′ is CR18.
4. The compound according to claim 1 , wherein:
x is CR11;
y is CR12;
z is CR13;
r is CR14 or N;
x′ is CR15;
y′ is CR16;
z′ is CR17; and
r′ is CR18 or N.
5. The compound according to claim 1 , wherein:
x is CR11;
y is CR12;
z is CR13;
r is N;
x′ is CR15;
y′ is CR16;
z′ is CR17; and
r′ is N.
6. The compound according to claim 1 , wherein:
x is CR11;
y is CR12;
z is CR13;
r is N;
x′ is CR15;
y′ is CR16;
z′ is CR17;
r′ is N; and
wherein R11, R12, R13, R15, R16, and R17 are hydrogen.
7. The compound according to claim 1 , wherein:
x is CR11;
y is CR12;
z is CR13;
r is N;
x′ is CR15;
y′ is CR16;
z′ is CR17;
r′ is N; and
R4, R5, R7 and R8 are independently hydrogen, halogen, hydroxyl, thiol, lower alkyl, substituted lower alkyl, alkoxy, alkylthio, acyl, aryloxy, amino, amido, carboxyl, aryl, substituted aryl, nitro, cyano, —CONHHN 2 or —S(O) 0-2 R wherein R is alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, heteroaryl, substituted heterocycle, or substituted heteroaryl; and
wherein R11, R12, R13, R15, R16, and R17 are hydrogen.
8. The compound according to claim 1 , wherein:
x is CR11;
y is CR12;
z is CR13;
r is N;
x′ is CR15;
y′ is CR16;
z′ is CR17;
r′ is N; and
R4 is hydrogen;
R5, R7 and R8 are independently hydrogen, halogen, hydroxyl, thiol, lower alkyl, substituted lower alkyl, alkoxy, alkylthio, acyl, aryloxy, amino, amido, carboxyl, aryl, substituted aryl, nitro, cyano, —CONHHN 2 or —S(O) 0-2 R wherein R is alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, heteroaryl, substituted heterocycle, or substituted heteroaryl; and
wherein R11, R12, R13, R15, R16, and R17 are hydrogen.
9. The compound according to claim 1 , wherein:
x is CR11;
y is CR12;
z is CR13;
r is N;
x′ is CR15;
y′ is CR16;
z′ is CR17;
r′ is N; and
R4 is hydrogen;
R5, R7 and R8 are independently hydrogen, halogen, hydroxyl, thiol, lower alkyl, substituted lower alkyl, alkoxy, alkylthio, acyl, aryloxy, amino, amido, carboxyl, aryl, substituted aryl, nitro, cyano, —CONHHN 2 or —S(O) 0-2 R wherein R is alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, heteroaryl, substituted heterocycle, or substituted heteroaryl;
R10 is lower alkyl, substituted lower alkyl, methoxy, acyl or —SO 2 PhCH 3 ; and R11, R12, R13, R15, R16, and R17 are hydrogen.
10. The compound according to claim 1 , wherein:
x is CR11;
y is CR12;
z is CR13;
r is N;
x′ is CR15;
y′ is CR16;
z′ is CR17;
r′ is N; and
R4 is hydrogen;
R5, R7 and R8 are independently hydrogen, halogen, hydroxyl, thiol, lower alkyl, substituted lower alkyl, alkoxy, alkylthio, acyl, aryloxy, amino, amido, carboxyl, aryl, substituted aryl, nitro, cyano, —CONHHN 2 or —S(O) 0-2 R wherein R is alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, heteroaryl, substituted heterocycle, or substituted heteroaryl;
R10 is hydrogen; and
R11, R12, R13, R15, R16, and R17 are hydrogen.
11. The compound according to claim 1 , selected from:
12. The compound according to claim 1 , selected from:
13. The compound according to claim 1 , wherein said compound is:
14. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.